Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03799614 · ClinicalTrials.gov registry record · NA
Vibration Impact on Parkinson's Tremor
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03799614 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 30 participants.
The verdict
NCT03799614, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The primary purpose of this study is to test the safety, tolerability and efficacy of vibration (delivered by an experimental device called RMBand that is worn on the subject's arm) on parkinsonian tremor. The RMBand was developed by Resonate Forward, LLC (RF). This RMBand is designed to administer a vibration to the wearer to decrease or stop tremor in persons with Parkinson's disease (PD).
Interventions
- DEVICE RMBand lower dose
- DEVICE RMBand higher dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-02-26 |
| Est. Completion | 2019-11-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03799614
The ClinicalTrials.gov registry entry for NCT03799614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RMBand lower dose is the first listed.
NCT03799614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03799614 about?
NCT03799614 is a clinical study titled "Vibration Impact on Parkinson's Tremor". The primary purpose of this study is to test the safety, tolerability and efficacy of vibration (delivered by an experimental device called RMBand that is worn on the subject's arm) on parkinsonian tremor. The RMBand was developed by Resonate Forward, LLC (RF). This RMBand is designed to administer ...
What is the current status of trial NCT03799614?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-02-26. Estimated completion is 2019-11-27.
What interventions are being tested in trial NCT03799614?
The interventions under investigation include: RMBand lower dose (DEVICE), RMBand higher dose (DEVICE).
Who is sponsoring clinical trial NCT03799614?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.